Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

被引：0
|
作者：
Seoyoung C. Kim
Robert J. Glynn
Jun Liu
Brendan M. Everett
Allison B. Goldfine
机构：
[1] Brigham and Women’s Hospital,Division of Pharmacoepidemiology and Pharmacoeconomics
[2] Brigham and Women’s Hospital,Division of Rheumatology, Allergy and Immunology
[3] Brigham and Women’s Hospital,Division of Cardiovascular Medicine
[4] Joslin Diabetes Center,Clinical Research
来源：
Acta Diabetologica | 2014年 / 51卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Type 2 diabetes; Cardiovascular disease; Heart failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1023
页数：8
相关论文
共 50 条
  • [21] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Geng, Jinsong
    Yu, Hao
    Mao, Yiwei
    Zhang, Peng
    Chen, Yingyao
    PHARMACOECONOMICS, 2015, 33 (06) : 581 - 597
  • [22] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [23] Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy
    Yen, Fu-Shun
    Chiang, Jen-Huai
    Pan, Chun-Wei
    Lin, Boniface J.
    Wei, James Cheng-Chung
    Hsu, Chih-Cheng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 140 : 279 - 287
  • [24] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (06) : 508 - 510
  • [25] Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Wood, Lindy
    Campbell, R. Keith
    PHARMACOTHERAPY, 2010, 30 (05): : 463 - 484
  • [26] Potential Impact of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Pathophysiology in Type 2 Diabetes Mellitus
    Davidson, Michael H.
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 56 - 65
  • [27] The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus
    Yousefzadeh, Pegah
    Wang, Xiangbing
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [28] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (02) : 17 - 19
  • [29] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
    Kim, Young-Gun
    Kim, Seirhan
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Kim, Hae Jin
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [30] Dipeptyl peptidase-4 inhibitors in type 2 diabetes: Cardiovascular risk reduction?
    Zarowitz, Barbara J.
    GERIATRIC NURSING, 2013, 34 (06) : 498 - 499
12345